Literature DB >> 1198074

Death rate and causes of death in patients with rheumatoid arthritis.

H A Isomäki, O Mutru, K Koota.   

Abstract

Patients with rheumatoid arthritis, 500 males and 500 females, aged 40 years or over, and an age- and sex-matched control population were observed over a 3-year period. During the follow-up, 122 RA patients and 69 controls had died. The most common causes of death in RA patients were cardiovascular diseases (57 patients), renal failure (27 patients), infections (19 patients), and malignant neoplasms (11 patients); in the controls, the respective data are: cardiovascular diseases (35 people), malignant neoplasms (21 people), accidents (7 people), and infections (5 people).

Entities:  

Mesh:

Year:  1975        PMID: 1198074     DOI: 10.3109/03009747509165257

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  20 in total

Review 1.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

2.  A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis.

Authors:  Rachana Mishra; Aastha Singh; Vishal Chandra; Mahendra P S Negi; Baishnab C Tripathy; Jaya Prakash; Varsha Gupta
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

3.  Secondary acute myeloid leukaemia with 7q- complicating azathioprine treatment for rheumatoid arthritis.

Authors:  C C Mok; Y L Kwong; C S Lau
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

4.  Dyslipoproteinaemia in a subset of patients with rheumatoid arthritis.

Authors:  A Kavanaugh
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

5.  The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.

Authors:  J A Baltus; J W Boersma; A P Hartman; J P Vandenbroucke
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

6.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

7.  Polymorphism of the beta3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine.

Authors:  J F Muñoz-Valle; M Vázquez-Del Mercado; S Ruiz-Quezada; E Oregón-Romero; R E Navarro-Hernández; J Ramírez-Barragán; G Martínez-Bonilla; G Bernard-Medina; B E Bastidas-Ramírez; B Ruiz-Madrigal; A Panduro
Journal:  Rheumatol Int       Date:  2003-03-12       Impact factor: 2.631

Review 8.  Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa?

Authors:  T Pincus; T Sokka
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

9.  Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis.

Authors:  M Laakso; O Mutru; H Isomäki; K Koota
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

Review 10.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.